|
KIAA1826 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.01959999945878E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62503344114384E-12 |
| Stage1-vs-Stage2 |
1.805030E-01 |
| Stage1-vs-Stage3 |
4.900500E-02 |
| Stage1-vs-Stage4 |
5.774000E-04 |
| Stage2-vs-Stage3 |
1.313500E-02 |
| Stage2-vs-Stage4 |
3.229700E-04 |
| Stage3-vs-Stage4 |
7.117800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.02771174587724E-14 |
| Normal-vs-AfricanAmerican |
6.2171000003719E-07 |
| Normal-vs-Asian |
2.8219999670398E-09 |
| Caucasian-vs-AfricanAmerican |
5.557800E-01 |
| Caucasian-vs-Asian |
2.390800E-01 |
| AfricanAmerican-vs-Asian |
8.134800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.175170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6251444634463E-12 |
| Normal-vs-Age(81-100Yrs) |
2.649400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.883000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.453800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.997400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.464800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.685000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.565400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.501660E-02 |
| Classical-VS-Follicular |
1.249600E-01 |
| Classical-VS-Other |
5.284000E-01 |
| Classical-VS-Normal |
5.19373433149894E-12 |
| Tall-VS-Follicular |
6.832300E-04 |
| Tall-VS-Other |
5.259000E-01 |
| Tall-VS-Normal |
2.39808173319034E-14 |
| Follicular-VS-Other |
3.442400E-01 |
| Follicular-VS-Normal |
1.11829999704938E-08 |
| Other-VS-Normal |
5.569300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-16 |
| Normal-vs-N1 |
2.8199664825479E-14 |
| N0-vs-N1 |
6.639500E-03 |
|
|
